dualyx

Technologiepark-Zwijnaarde 94

9052 Gent

BE

dualyx

Foundation date

21/11/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need.

Upcoming events

Latest news

  • Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation

    9 hours ago

  • argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

    1 day ago

  • ExeVir Announces Michael Garrett as New Chief Executive Officer

    Tuesday November 19th 2024